Management of Leimyosarcoma: A Survey Among Members of the Korean Gynecologic Oncology Group. Issue 9 (1st November 2017)

• Record Type: Journal Article
• Authors: Kim, Mi Kyoung; Lee, Taek Sang; Kim, Jae-Weon; Lee, Jong-Min; Kim, Beob Jong; Seong, Seok Ju
• Is Part Of: International journal of gynecological cancer. Volume 27:Issue 9(2017)
• Page Start: 1912
• Page End: 1918
• Publication Date: 2017-11-01
• Subjects: Uterine leiomyosarcoma -- Survey -- Treatment; Generative organs, Female -- Cancer -- Periodicals; 616.99465
• DOI: 10.1097/IGC.0000000000001104
• Languages: English
• ISSNs: 1048-891X

Abstract

Abstract : Objective: This study aimed to investigate current clinical management of leiomyosarcoma (LMS) in Korea. Materials and Methods: We conducted a Web-based survey among members of the Korean Gynecologic Oncology Group regarding their treatment of LMS. Results: In total, 77 (27.8%) of 277 members responded to the survey. For surgical treatment of stage I LMS, 26.8% indicated total hysterectomy only and 16.9% indicated total hysterectomy with bilateral salpingo-oophorectomy. Also, lymph node dissection was indicated by 54.9% of respondents, whereas 46.5% stated that bilateral salpingo-oophorectomy could be omitted in young patients. More than half (57.7%) of the respondents recommended against adjuvant treatment. For stage I LMS diagnosed after morcellation, 79.2% of the respondents recommended lymph node dissection and 56.4% recommended adjuvant therapy. As for advanced-stage LMS, in cases of complete resection, adjuvant chemotherapy was preferred by 63.1%. For incomplete resection, combined radiotherapy/chemotherapy was the most preferred adjuvant therapy (63.1%). Conclusions: Among Korean Gynecologic Oncology Group members, there are many discrepancies in the clinical management of LMS. A large-scale prospective study to establish treatment guidelines is needed.